Replimune Group Inc (REPL)
6.95
+0.39
(+5.95%)
USD |
NASDAQ |
May 03, 16:00
6.965
+0.02
(+0.22%)
After-Hours: 20:00
Replimune Group Cash from Operations (TTM): -172.10M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -172.10M |
September 30, 2023 | -153.56M |
June 30, 2023 | -143.18M |
March 31, 2023 | -128.05M |
December 31, 2022 | -117.81M |
September 30, 2022 | -107.57M |
June 30, 2022 | -97.32M |
March 31, 2022 | -82.18M |
December 31, 2021 | -75.75M |
September 30, 2021 | -70.40M |
June 30, 2021 | -64.61M |
March 31, 2021 | -61.39M |
Date | Value |
---|---|
December 31, 2020 | -56.52M |
September 30, 2020 | -59.27M |
June 30, 2020 | -62.06M |
March 31, 2020 | -60.55M |
December 31, 2019 | -55.32M |
September 30, 2019 | -45.69M |
June 30, 2019 | -32.10M |
March 31, 2019 | -25.38M |
December 31, 2018 | -23.58M |
September 30, 2018 | -20.17M |
June 30, 2018 | -17.38M |
March 31, 2018 | -16.01M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-172.10M
Minimum
Dec 2023
-32.10M
Maximum
Jun 2019
-86.60M
Average
-70.40M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
Esperion Therapeutics Inc | -135.49M |
Gossamer Bio Inc | -159.16M |
NovaBay Pharmaceuticals Inc | -4.131M |
Palatin Technologies Inc | -26.54M |
iBio Inc | -18.89M |